Clinical trials - Press Releases

Date	Title	Company
22-Feb-2023	Pharma Targeting Celebrates 10 years of Connecting People Intelligently	Pharma Targeting
22-Feb-2023	AELIX Therapeutics presents positive results from randomized placebo-controlled phase IIa therapeutic HIV vaccine and immune modulator combination clinical trial	AELIX Therapeutics
21-Feb-2023	A preclinical trial by the U.S. National Institutes of Health validates the efficacy of Uric Acid for ischaemic stroke	FreeOx Biotech
21-Feb-2023	Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update	Kinarus Therapeutics
21-Feb-2023	EU Diabetic Foot Ulcer Clinical Study Initiated in Ireland	Spectral MD Holdings, Ltd
20-Feb-2023	Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona	Phastar
17-Feb-2023	Understanding the Scope of Pharmacovigilance Courses	TechnoBridge Systems
10-Feb-2023	Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific	Novotech Health Holdings Pte Ltd
09-Feb-2023	BSI LIFE SCIENCES AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS	BSI Life Sciences & Ledger Run
08-Feb-2023	Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI	Syneos Health
07-Feb-2023	TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials	TILT Biotherapeutics
06-Feb-2023	RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies	CluePoints
03-Feb-2023	Asia Pacific Cell & Gene Research Growing 50% Faster than ROW	Novotech, Asia Pacific CRO
03-Feb-2023	New Phesi analysis reveals almost a fifth of investigator sites in cancer trials have recruited only one patient	Phesi Inc
03-Feb-2023	Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy or in combination with check point inhibitors in patients with advanced melanoma	Anaveon
02-Feb-2023	AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials	AARDEX Group
01-Feb-2023	MURAL HEALTH AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS	Mural Health
26-Jan-2023	AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial	AC Immune SA
26-Jan-2023	Cherwell publishes new guide to EM best practice in compliance with revised Annex 1	Cherwell Laboratories
26-Jan-2023	Future of clinical research in the NHS in jeopardy without urgent action, warns Lords Committee	House of Lords